IDiyas

For the Inventor, By the Inventor

Metuchen, NJ, United States of America

Chad E Bennett

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 8.3

ph-index = 3

Forward Citations = 69(Granted Patents)


Company Filing History:

goldMedal6 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
silverMedal4 out of 1,829 
 
Schering Corporation
 patents
bronzeMedal1 out of 28 
 
Schering-plough Corporation
 patents
4. 1 out of 832,680 
Other
 patents

Years Active: 2009-2016

Loading Chart...
Loading Chart...
12 patents (USPTO):
1. 9499502 - 5-substituted iminothiazines and their mono- and dioxides as BACE inhibitors, compositions, and their use (2016-11-22),
2. 9181236 - 2-spiro-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions and their use (2015-11-10),
3. 8907086 - Fused bicyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors (2014-12-09),
4. 8809318 - Gamma secretase modulators (2014-08-19),
5. 8673900 - Gamma secretase modulators (2014-03-18),
6. 8569521 - Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors (2013-10-29),
7. 8450343 - Gamma secretase modulators (2013-05-28),
8. 8067621 - Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors (2011-11-29),
9. 7884080 - Azetidinone derivatives and methods of use thereof (2011-02-08),
10. 7767815 - Fused tricyclic mGluR1 antagonists as therapeutic agents (2010-08-03),
11. 7687501 - Pyridothienopyridazinone derivatives as mGluR1 antagonists (2010-03-30),
12. 7638526 - Azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolism (2009-12-29),

Title: Chad E Bennett: Innovator in Pharmaceutical Chemistry

Introduction

Chad E Bennett is a notable inventor based in Metuchen, NJ (US), recognized for his contributions to pharmaceutical chemistry. With a total of 12 patents to his name, Bennett has made significant strides in the development of compounds that may aid in the treatment of various diseases, including Alzheimer's disease.

Latest Patents

Bennett's latest patents include innovative compounds such as 5-substituted iminothiazines and their mono- and dioxides, which serve as BACE inhibitors. These compounds are detailed in his patent, which discloses certain iminothiazine compounds and their pharmaceutically acceptable salts. The invention highlights the potential of these compounds in treating and preventing pathologies related to Alzheimer's disease. Another significant patent involves 2-spiro-substituted iminothiazines and their mono- and dioxides, further emphasizing their utility as BACE inhibitors.

Career Highlights

Throughout his career, Chad E Bennett has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and Schering Corporation. His work in these organizations has contributed to the advancement of drug development and innovation in the field.

Collaborations

Bennett has collaborated with notable colleagues such as Duane A Burnett and Chad E Knutson, enhancing the scope and impact of his research and inventions.

Conclusion

Chad E Bennett's work exemplifies the importance of innovation in pharmaceutical chemistry, particularly in the development of treatments for Alzheimer's disease. His contributions through patents and collaborations continue to influence the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…